A genome-wide methylation study on obesity: Differential variability and differential methylation

Epigenetics

Volumn 8, Issue 5, 2013, Pages 522-533

  Xu, Xiaojing ^a   Su, Shaoyong ^a   Barnes, Vernon A ^a   De Miguel, Carmen ^a   Pollock, Jennifer ^a   Ownby, Dennis ^a   Shi, Huidong ^a   Zhu, Haidong ^a   Snieder, Harold ^b   Wang, Xiaoling ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blacks; Epigenome wide association study (EWAS); Genome wide association study (GWAS); Methylation variation; Obesity

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONCOGENE; PATHOGENESIS; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 84877342168     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.24506     Document Type: Article

References (21)

1. Feinberg AP, Irizarry RA. Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci U S A 2010; 107(Suppl 1):1757-64; PMID:20080672; http://dx.doi.org/10.1073/pnas.0906183107.
2. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768-75; PMID:21706001; http://dx.doi.org/10.1038/ng.865.
3. Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med 2012; 4:24; PMID:22453031; http://dx.doi.org/10.1186/gm323.
4. Teschendorff AE, Widschwendter M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics 2012; 28:1487-94; PMID:22492641; http://dx.doi.org/10.1093/bioinformatics/bts170.
5. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6:e1000058; PMID:19399161; http://dx.doi. org/10.1371/journal.pmed.1000058.
6. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93(Suppl 1):S9-30; PMID:18987276; http://dx.doi.org/10.1210/jc.2008-1595.
7. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al.; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898-918; PMID:16380542; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.171016.
8. El-Atat F, Aneja A, Mcfarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am 2003; 32:823-54; PMID:14711064; http://dx.doi. org/10.1016/S0889-8529(03)00070-7.
9. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004; 27:2568-9, author reply 2569; PMID:15451946; http://dx.doi.org/10.2337/diacare.27.10.2568.
10. Anderson AS, Caswell S. Obesity management--an opportunity for cancer prevention. Surgeon 2009; 7:282-5; PMID:19848061; http://dx.doi.org/10.1016/S1479-666X(09)80005-X.
11. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13:741-51; PMID:12420953; http://dx.doi. org/10.1023/A:1020239211145.
12. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86:556-65; PMID:17823417.
13. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i-xii, 1-253; PMID:11234459.
14. Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010; 8:87; PMID:21176133; http://dx.doi.org/10.1186/1741-7015-8-87.
15. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T, et al. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2010; 2:49ra67; PMID:20844285; http://dx.doi.org/10.1126/scitranslmed. 3001262.
16. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012; 21:371-83; PMID:21994764; http://dx.doi.org/10.1093/hmg/ddr472.
17. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013; 31:142-7; PMID:23334450; http://dx.doi. org/10.1038/nbt.2487.
18. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 2012; 490:267-72; PMID:22982992; http://dx.doi. org/10.1038/nature11401.
19. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:e3; PMID:16646809; http://dx.doi.org/10.2202/1544-6115.1027.
20. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002; 99:6567-72; PMID:12011421; http://dx.doi. org/10.1073/pnas.082099299.
21. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9:811-8; PMID:2218183; http://dx.doi.org/10.1002/sim.4780090710.